Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Acute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in men.

Rubinow KB, Tang C, Hoofnagle AN, Snyder CN, Amory JK, Heinecke JW, Page ST.

Steroids. 2012 Apr;77(5):454-60. doi: 10.1016/j.steroids.2012.01.002. Epub 2012 Jan 15.

2.

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity.

Rubinow KB, Vaisar T, Tang C, Matsumoto AM, Heinecke JW, Page ST.

J Lipid Res. 2012 Jul;53(7):1376-83. doi: 10.1194/jlr.P026005. Epub 2012 Apr 13.

3.

Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system.

Dobs AS, Bachorik PS, Arver S, Meikle AW, Sanders SW, Caramelli KE, Mazer NA.

J Clin Endocrinol Metab. 2001 Mar;86(3):1026-33.

PMID:
11238481
4.

Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men.

Van Pottelbergh I, Braeckman L, De Bacquer D, De Backer G, Kaufman JM.

Atherosclerosis. 2003 Jan;166(1):95-102.

PMID:
12482555
5.

Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Hartgens F, Rietjens G, Keizer HA, Kuipers H, Wolffenbuttel BH.

Br J Sports Med. 2004 Jun;38(3):253-9.

6.
7.

Suppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and apoproteins A-I and B.

Goldberg RB, Rabin D, Alexander AN, Doelle GC, Getz GS.

J Clin Endocrinol Metab. 1985 Jan;60(1):203-7.

PMID:
3917267
8.

Effects of transdermal application of 7-oxo-DHEA on the levels of steroid hormones, gonadotropins and lipids in healthy men.

Sulcová J, Hill M, Masek Z, Ceska R, Novácek A, Hampl R, Stárka L.

Physiol Res. 2001;50(1):9-18.

10.

Estrogen, testosterone, and sequential movement in men.

Siegel JA, Young LA, Neiss MB, Samuels MH, Roselli CE, Janowsky JS.

Behav Neurosci. 2008 Oct;122(5):955-62. doi: 10.1037/a0013045.

11.

Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.

Roe A, Hillman J, Butts S, Smith M, Rader D, Playford M, Mehta NN, Dokras A.

J Clin Endocrinol Metab. 2014 May;99(5):E841-7. doi: 10.1210/jc.2013-3918. Epub 2014 Feb 10.

13.

Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels.

Bagatell CJ, Knopp RH, Vale WW, Rivier JE, Bremner WJ.

Ann Intern Med. 1992 Jun 15;116(12 Pt 1):967-73.

PMID:
1586105
14.

Beneficial effects of testosterone undecanoate on the lipoprotein profiles in healthy elderly men. A placebo controlled study.

Uyanik BS, Ari Z, Gümüs B, Yiğitoğlu MR, Arslan T.

Jpn Heart J. 1997 Jan;38(1):73-82.

PMID:
9186283
15.

Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk.

Dickerman RD, McConathy WJ, Zachariah NY.

J Cardiovasc Risk. 1997 Oct-Dec;4(5-6):363-6.

PMID:
9865668
16.
17.

Effects of testosterone suppression in young men by the gonadotropin releasing hormone antagonist cetrorelix on plasma lipids, lipolytic enzymes, lipid transfer proteins, insulin, and leptin.

Büchter D, Behre HM, Kliesch S, Chirazi A, Nieschlag E, Assmann G, von Eckardstein A.

Exp Clin Endocrinol Diabetes. 1999;107(8):522-9.

PMID:
10612483
18.

Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.

Leder BZ, Finkelstein JS.

Osteoporos Int. 2005 Dec;16(12):1487-94. Epub 2005 Apr 23.

PMID:
15856361
19.

Physiological levels of estradiol stimulate plasma high density lipoprotein2 cholesterol levels in normal men.

Bagatell CJ, Knopp RH, Rivier JE, Bremner WJ.

J Clin Endocrinol Metab. 1994 Apr;78(4):855-61.

PMID:
8157711
20.

Relationships between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variables.

Tchernof A, Labrie F, Bélanger A, Prud'homme D, Bouchard C, Tremblay A, Nadeau A, Després JP.

Atherosclerosis. 1997 Sep;133(2):235-44.

PMID:
9298684

Supplemental Content

Support Center